Methylprednisolone

BreastfeedingPediatric

Anaphylactoid reactions / anaphylaxis (includes anaphylactic shock) 

(2015): Alvarez Caro F+, J Investig Allergol Clin Immunol 25(4), 309

(2014): Faria E+, J Investig Allergol Clin Immunol 24(1), 40 (2 cases)

(2012): Atanaskovic-Markovic M+, Srp Arh Celok Lek 140(3-4), 233

(2004): Saito R+, Int J Urol 11(3), 171 [REVIEW]

(2002): Burgdorff T+, Ann Allergy Asthma Immunol 89(4), 425

(2000): Young MF+, J Neurol Neurosurg Psychiatry 68(2), 255

(1999): Beynel P+, Rev Mal Respir 16(4), 529 [REVIEW]

(1999): Schonwald S, Am J Emerg Med 17(6), 583 [REVIEW]

(1997): Mace S+, J Rheumatol 24(6), 1191 [REVIEW]

(1997): van den Berg JS+, J Neurol Neurosurg Psychiatry 63(6), 813

(1996): Moreno-Ancillo A+, J Allergy Clin Immunol 97(5), 1169

(1993): Hopper JM+, J Bone Joint Br 75(3), 505 [REVIEW] (with bupivacaine)

(1993): Watanabe I+, Masui 42(1), 112

(1991): Peces R+, Nephron 59(3), 497

(1990): Laine-Cessac P+, Therapie 45(6), 505 [REVIEW]

Bruise / bruising / contusion / ecchymosis (ecchymoses) 

(1998): Dasgupta B+, Br J Rheumatol 37(2), 189

(1991): Anderson B+, Intern Med 151

Contact dermatitis 

(2013): D\'Erme AM+, G Ital Dermatol Venereol 148(3), 307

Dermatitis 

(2004): Cahill J+, Australas J Dermatol 45(3), 192

(2000): Chew AL+, Cutis 65(5), 307

(1998): Corazza M+, Contact Dermatitis 38(6), 356

(1997): Balato N+, Am J Contact Dermat 8(1), 24-5

(1992): Aramoto Y+, J Dermatol 19(6), 375

Erythroderma 

(1991): Fernandez de+, Contact Dermatitis 25(1), 68-7

Facial flushing 

(2016): Jongen PJ+, J Neurol 263(8), 164161%

Flushing / rubefaction 

(2002): Mignogna MD+, J Oral Pathol Med 31(6), 339

(1993): Chrousos GA+, JAMA 269(16), 2110

Herpes simplex 

(2009): Meydani A+, Acta Dermatovenerol Alp Panonica Adriat 18 (3), 135 (following intra-articular injection)

Hypersensitivity 

(2006): Sirvent AE+, Nefrologia 26(1), 128

(2006): Venturini M+, J Investig Allergol Clin Immunol 16(1), 51

(1996): Lopez-Serrano MC+, J Investig Allergol Clin Immunol 6(5), 324

Kaposi's sarcoma 

(2004): Monti M+, J Eur Acad Dermatol Venereol 18(2), 191

Lymphoproliferative disease 

(2002): Theate I+, Eur J Haematol 69(4), 248 (with methotrexate)

Perioral dermatitis 

(2001): Chow ET, Australas J Dermatol 42(1), 62

Pruritus (itching) 

(2005): Hardy D, Can J Anaesth 52(2), 186 (with bupivacaine and epinephrine)

(2002): Mignogna MD+, J Oral Pathol Med 31(6), 339

Rash 

(2004): Kuga A+, Rinsho Shinkeigaku 44(10), 691 [REVIEW]

(2001): Macchia PE+, J Endocrinol Invest 24(3), 152

Stevens-Johnson syndrome 

(2002): Samimi SS+, Pediatr Dermatol 19(1), 52

Urticaria / hives 

(2011): Jang EJ+, Allergy Asthma Immunol Res 3(4), 277

(2001): Borja JM+, Allergy 56(8), 791

(2001): Pollack B+, Br J Dermatol 144, 1228

(1996): Pizzuti P+, Rev Rhum Engl Ed 63(3), 223 [REVIEW]

(1990): Sieck JO+, Br J Clin Pract 44(12), 723

Mucocutaneous reactions 

(2002): Wiland P+, Pol Arch Med Wewn (Polish) 108(5), 1055 (with gold (aurothiomalate))

Arrhythmias 

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(1991): Chikanza C+, Br J Rheumatol 30(5), 392

Bradyarrhythmia 

(2020): Ghosh A+, Cardiol Young Dec, Online ahead of print (1 case / female)Pediatric

Bradycardia / sinus bradycardia 

(2015): Stroeder J+, Can Pharm J (Ott) 148(5), 235 [REVIEW]

(2013): Darling HS+, J Assoc Physicians India 61(12), 920

(2005): Chibane S+, Rev Med Interne 26(1), 2010%

(2001): Pudil R+, Arch Intern Med 161(14), 1778

(1998): Guillen EL+, Am J Kidney Dis 32(2), E4

(1998): Kucukosmanoglu O+, Nephron 80(4), 484

Cardiac arrest 

(2015): Massart A+, Clin Nephrol 83(1), 61 (with basiliximab, mycophenolate and tacrolimus)

Cardiomyopathy 

(2006): Dani C+, Pediatrics 117(5), 1866

Hypertension 

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2005): Chibane S+, Rev Med Interne 26(1), 20

(2005): Hardy D, Can J Anaesth 52(2), 186 (with bupivacaine and epinephrine)

(2003): Cortes-Hernandez J+, Lupus 12(4), 287

(1992): Baethge BA+, Ann Pharmacother 26(3), 316

Hypotension 

(1998): Guillen EL+, Am J Kidney Dis 32(2), E4

Myocardial infarction 

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

Myocardial ischemia 

(2005): Chibane S+, Rev Med Interne 26(1), 202%

Myocardial toxicity 

(2004): Kulig G+, Przegl Lek 61(8), 855

(1993): Cohen IJ, Pediatr Hematol Oncol 10(3), v [REVIEW]

Palpitation 

(2002): Mignogna MD+, J Oral Pathol Med 31(6), 339

Shock (see also anaphylactic shock) 

(2015): Massart A+, Clin Nephrol 83(1), 61 (with basiliximab, mycophenolate and tacrolimus)

Agitation 

(2016): Jongen PJ+, J Neurol 263(8), 164136%

Arachnoiditis 

(2017): Schlatter J+, Eur Spine J Nov, Epub ahead of print (via intrathecal administration)

Depression 

(2012): Tamura S+, Rinsho Ketsueki 53(3), 361

(2003): Antonijevic IA+, Psychoneuroendocrinology 28(6), 780

(2002): Kulakowska A+, Pol Merkuriusz Lek 13(75), 200

(1996): Naber D+, Psychoneuroendocrinology 21(1), 25-3

(1993): Chrousos GA+, JAMA 269(16), 2110

Dysgeusia (taste perversion) 

(2016): Jongen PJ+, J Neurol 263(8), 164161%

(2009): Topak M+, J Laryngol Otol 123 (11), 1221

(2001): Macchia PE+, J Endocrinol Invest 24(3), 152

(1994): Chassard D+, Presse Med 23(11), 515

Hallucinations, visual 

(2011): Samala RV+, J Am Med Dir Assoc 12(8), 609 [REVIEW]

Headache 

(2017): Schlatter J+, Eur Spine J Nov, Epub ahead of print [REVIEW] (via intrathecal administration)

(2002): Mignogna MD+, J Oral Pathol Med 31(6), 339

Insomnia 

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

Meningococcal infection 

(2017): Schlatter J+, Eur Spine J Nov, Epub ahead of print [REVIEW] (via intrathecal administration)

Neurotoxicity 

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2004): Fodale V+, Br J Anaesth 92(2), 289 (with cisatracurium)

Pain 

(2009): Topak M+, J Laryngol Otol 123 (11), 1221 (burning sensation in throat)

Paralysis 

(2016): Zhang YL+, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (Chinese) 51(10), 783

Psychosis 

(2015): Tandon VR+, Indian J Med Res 142(1), 33

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2014): Ohashi T, Nihon Rinsho (Japanese) 72(11), 1995

Seizures 

(1996): Vaughn BV+, Epilepsia 37(12), 1175

(1992): Baethge BA+, Ann Pharmacother 26(3), 316

(1991): Bettinelli A+, Child Nephrol Urol 11(1), 41-3

Sleep disturbances 

(2016): Jongen PJ+, J Neurol 263(8), 164144%

Vertigo / dizziness 

(2009): Topak M+, J Laryngol Otol 123 (11), 1221

(2005): Hardy D, Can J Anaesth 52(2), 186 (with bupivacaine and epinephrine)

Diabetes mellitus 

(2015): Tandon VR+, Indian J Med Res 142(1), 33

Diabetic ketoacidosis 

(2020): Alakkas Z+, Am J Case Rep 21, e923372 (1 case)

(2008): Cagdas DN+, J Cardiovasc Pharmacol Ther 13(4), 298 (1 case)Pediatric

Hyperglycemia (includes glucose increased) 

(2020): Alakkas Z+, Am J Case Rep 21, e923372 (1 case)

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2014): Ohashi T, Nihon Rinsho (Japanese) 72(11), 1995

(2010): Chebane L+, Therapie (French) 65(5), 447

Hypokalemia 

(2020): Ghosh A+, Cardiol Young Dec, Online ahead of print (1 case / female)Pediatric

(2016): Zhang YL+, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (Chinese) 51(10), 783

Abdominal pain 

(2016): Jongen PJ+, J Neurol 263(8), 164153%

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

(1994): Chassard D+, Presse Med 23(11), 515

Gastrointestinal bleeding 

(2016): Evaniew N+, J Neurotrauma 33(5), 468 [REVIEW]

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI) 

(2018): Rotondo E+, BMJ Case Rep 11(1)1 casePediatric

(2016): Davidov Y+, J Dig Dis 17(1), 55 [REVIEW]

(2015): Ferraro D+, Neurologist 19(6), 153 (4 cases)

(2014): Melamud B+, Isr Med Assoc J 16(3), 180

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2011): Furutama D+, Med Princ Pract 20(3), 291Pediatric

(2010): Loraschi A+, Clin Neuropharmacol 33 (1), 52

(2008): Rivero Fernandez M+, Rev Esp Enferm Dig 100(11), 720 (1 case)

(2006): Topal F+, Ann Pharmacother 40(10), 1868

Nausea 

(2016): Jongen PJ+, J Neurol 263(8), 164153%

Pancreatitis / acute pancreatitis 

(2012): Tamura S+, Rinsho Ketsueki (Japanese) 53(3), 361

Bladder disorder 

(2017): Schlatter J+, Eur Spine J Nov, Epub ahead of print [REVIEW] (via intrathecal administration)

Febrile neutropenia 

(2014): Montoro J+, Transfus Apher Sci 50(3), 411 (as R-ESHAP chemotherapy (with rituximab, etoposide, cytarabine and cisplatin) plus pegfilgastrim)

Hemotoxicity 

(2012): Pettitt AR+, J Clin Oncol 30(14), 164767% (grade 3 to 4) (with alemtuzumab)

Leukocytopenia (leukopenia) 

(2002): Wiland P+, Pol Arch Med Wewn (Polish) 108(5), 1055 (with gold (aurothiomalate))

Myelosuppression / bone marrow suppression / myelotoxicity 

(2014): Montoro J+, Transfus Apher Sci 50(3), 411 (as R-ESHAP chemotherapy (with rituximab, etoposide, cytarabine and cisplatin) plus pegfilgastrim)

Thrombocytopenia 

(2010): Royer B+, Blood 115(26), 5431

Injection-site lipoatrophy/lipohypertrophy 

(2000): Anderson B+, Arch Intern Med 151, 153

Injection-site pain 

(2009): Topak M+, J Laryngol Otol 123 (11), 1221

Arthralgia 

(2015): Tandon VR+, Indian J Med Res 142(1), 33

(2001): Odabas AR+, Nephron 87(1), 95

Asthenia / fatigue 

(2002): Mignogna MD+, J Oral Pathol Med 31(6), 339

Myalgia/Myositis/Myopathy/Myotoxicity (see also Statin-induced necrotizing autoimmune myopathy) 

(2006): Lee HJ+, Bone Marrow Transplant 38(4), 299

(2005): Qian T+, Spinal Cord 43(4), 199

(2001): Odabas AR+, Nephron 87(1), 95

(2000): Qian T+, Med Hypotheses 55(5), 452

Myasthenia gravis 

(2015): Fujiwara A+, Ann Thorac Surg 99(1), e11

Osteonecrosis / avascular necrosis 

(2014): Dilisio MF, Orthopedics 37(7), e631

(2014): Ohashi T, Nihon Rinsho (Japanese) 72(11), 1995

(2004): Tanaka Y, Nippon Rinsho 62(10), 1867 [REVIEW]

(1998): Wing PC+, Spinal Cord 36(9), 633

(1996): Saisu T+, Transplant Proc 28(3), 1559

(1994): Bradbury G+, J Bone Joint Surg Am 76(9), 1385

(1993): Marsh JC+, Br J Haematol 84(4), 731

(1992): Massardo L+, Lupus 1(6), 40119%

(1992): O'Brien TJ+, Clin Orthop Relat Res (279), 176

Osteoporosis 

(2004): Haugeberg G+, Ann Rheum Dis 63(8), 940

(2003): de Deus RB+, Nephron Clin Pract 94(3), c69

Tendinopathy/Tendon rupture 

(2011): Pantalone A+, Int J Immunopathol Pharmacol 24(2), 519 (with ciprofloxacin)

(2005): Chiou YM+, Lupus 14(4), 321

Cataract 

(2003): Nakamura T+, Jpn J Ophthalmol 47(3), 254 (with cyclosporine)

(1999): Marsh P+, Ophthalmology 106(4), 811

(1992): Yokota S+, Ryumachi 32(3), 215

Conjunctival ulceration 

(1999): Zamir E+, Ophthalmic Surg Lasers 30(7), 565

Glaucoma 

(1995): Katsushima H, Nippon Ganka Gakkai Zasshi 99(2), 238 [REVIEW]

(1992): Yokota S+, Ryumachi 32(3), 215

Ocular pressure 

(1999): Marsh P+, Ophthalmology 106(4), 811

Ophthalmitis 

(2003): Mazur-Chlodek L+, Klin Oczna 105(3-4), 194

Periorbital urticaria 

(1992): John GR+, Am J Ophthalmol 113(5), 588

Visual disturbances 

(1991): Bettinelli A+, Child Nephrol Urol 11(1), 41

Proteinuria 

(2002): Wiland P+, Pol Arch Med Wewn (Polish) 108(5), 1055 (with gold (aurothiomalate))

Acute respiratory distress syndrome 

(2015): Massart A+, Clin Nephrol 83(1), 61 (with basiliximab, mycophenolate and tacrolimus)

Dysphonia 

(2006): Loeches-Yague B+, Med Clin (Barc) 126(2), 79

(2005): Hardy D, Can J Anaesth 52(2), 186 (with bupivacaine and epinephrine)

Pneumonia 

(2016): Wan QJ+, Exp Ther Med 12(3), 1934 (with tacrolimus)

Pulmonary embolism 

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

Adverse effects 

(2017): Patel P+, Br J Clin Pharmacol 83(10), 2148 [REVIEW] (pharmacokinetic interaction with aprepitant or fosaprepitant)

(2015): Gaydukova IZ+, Ter Arkh (Russian) 87(5), 47 (13 cases)

(2015): Riedl M+, J Endocrinol Invest 38(2), 17723%

(2015): Sun X+, Pulm Pharmacol Ther 31, 111

(2014): Machado-Alba JE+, Rev Panam Salud Publica 36(6), 396

(2005): Chibane S+, Rev Med Interne 26(1), 20

(1992): Pozzi C+, Nephron 60(2), 235

Allergic reactions 

(2003): Freymond N+, Rev Med Interne 24(10), 698

(2003): Ventura MT+, Br J Dermatol 148(1), 139

(1998): Vanpee D+, Ann Emerg Med 32(6), 754

Death 

(2014): Choi MS+, PLoS One 9(11), EpubGeriatric

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

Hiccups 

(2021): Egbu E+, Cureus 13(1), e12893 (1 case)

(2006): Iijima M+, Eur J Neurol 13(2), 201

(1986): Baethge BA+, Ann Intern Med 104(1), 58

Infection 

(2014): Miskiewicz P+, Endokrynol Pol 65(5), 402

(2012): Pettitt AR+, J Clin Oncol 30(14), 164751% (grade 3 to 4) (with alemtuzumab)

(2004): Kulig G+, Przegl Lek 61(8), 855

(2004): Offidani M+, Leuk Lymphoma 45(8), 1617

(2004): Tanaka Y, Nippon Rinsho 62(10), 1867 [REVIEW]

(1994): Sayer HG+, Blood 84(4), 1328

(1992): Baethge BA+, Ann Pharmacother 26(3), 316

Multiorgan failure 

(2015): Massart A+, Clin Nephrol 83(1), 61 (with basiliximab, mycophenolate and tacrolimus)



Adverse reactions attributed to entire drug class Corticosteroid / Glucocorticoid

Atrophy / Skin atrophy 

(2020): Niculet E+, Clin Cosmet Investig Dermatol 13, 1041-1050 [REVIEW]

Cushingoid features 

(2016): Matthews E+, Cochrane Database Syst Rev (5), CD003725 [REVIEW]

Hirsutism 

(2016): Matthews E+, Cochrane Database Syst Rev (5), CD003725 [REVIEW]

Behavioral disturbances / personality changes 

(2016): Matthews E+, Cochrane Database Syst Rev (5), CD003725 [REVIEW]

Cognitive impairment 

(2017): Ismail MF+, Future Oncol 13(29), 2719 [REVIEW]

Depression 

(2017): Ismail MF+, Future Oncol 13(29), 2719 [REVIEW]

(2011): Celano CM+, Dialogues Clin Neurosci 13(1), 109 [REVIEW]

Insomnia 

(2017): Ismail MF+, Future Oncol [REVIEW]

Mania 

(2017): Ismail MF+, Future Oncol 13(29), 2719 [REVIEW]

Mood changes 

(2017): Ismail MF+, Future Oncol 13(29), 2719 [REVIEW]

Neurotoxicity 

(2014): Prescrire Int 23(150), 153 (violent behavior)

Psychiatric adverse effect 

(2019): Staub Y+, J Oncol Pharm Pract Oct, Epub ahead of print65–78%Pediatric

Psychosis 

(2021): Huynh G+, J Pharm Technol 37(2), 120-126 [REVIEW] (13 cases)

(2017): Ismail MF+, Future Oncol 13(29), 2719 [REVIEW]

Sleep disturbances 

(2020): Cole JL, Fed Pract 37(6), 260-267 [REVIEW]

Diabetes mellitus 

(2016): Broder MS+, Semin Arthritis Rheum 46(2), 246 [REVIEW]

Hypoglycemia 

(2020): Delfs N+, J Clin Med 9(12), E40794%

Weight gain 

(2016): Matthews E+, Cochrane Database Syst Rev (5), CD003725 [REVIEW]

Gastrointestinal disorder / discomfort 

(2019): Qian G+, Int Urol Nephrol March, Epub ahead of print [REVIEW]

Pancreatitis / acute pancreatitis 

(2010): Lipsker D+, Dermatology 220 (3), 264

(2010): Ouakaa-Kchaou A+, Tunis Med 88 (2)

(2008): Bhavsar B+, JOP 9 (5), 664

(2008): Cagdas DN+, J Cardiovasc Pharmacol Ther 13 (4), 298

(2008): Tsuruoka K+, Nihon Jinzo Gakkai Shi 50 (7), 948

(2007): Fardet L+, Drug Saf 30 (10), 861

(2005): Trivedi CD+, J Clin Gastroenterol 39 (8), 709

(2003): Boruchowicz A+, Gastroenterol Clin Biol 27 (5), 560

Osteonecrosis / avascular necrosis 

(2021): Zgheib NK+, Per Med Aug, Online ahead of print7% (grade 4)Pediatric

Osteoporosis 

(2021): Cho SK+, Endocrinol Metab (Seoul) Jun, Online ahead of print [REVIEW]

(2020): Ward LM, Front Endocrinol (Lausanne) Dec, eCollectionPediatric

Cataract 

(2016): Broder MS+, Semin Arthritis Rheum 46(2), 246 [REVIEW]

(2010): Habot-Wilner Z+, Acta Ophthalmol 88 (8), e299

(2010): Lee SW+, Acta Ophthalmol 88 (8), e344

(2010): Taylor JB+, J Child Neurol 25 (8), 1017

(2010): Thorne JE+, Ophthalmology 117 (7), 1436

(2009): Weatherall M+, Respirology 14 (7), 983

(2008): Nerome Y+, Pediatr Int 50 (4), 541

(2007): James ER, J Ocul Pharmacol Ther 23 (5), 403

(2006): Conti SM+, Curr Opin Ophthalmol 17 (3), 235

(2006): Ernst P+, Eur Respir J 27 (6), 1168

(2006): Gartlehner G+, Ann Fam Med 4 (3), 253

Chorioretinopathy 

(2006): Bouyon A+, Rev Med Interne 27 (6), 487

Endophthalmitis 

(2006): Conti SM+, Curr Opin Ophthalmol 17 (3), 235

Glaucoma 

(2016): Broder MS+, Semin Arthritis Rheum 46(2), 246 [REVIEW]

(2010): Lee SW+, Acta Ophthalmol 88 (8), e344

(2007): El Afrit MA+, J Fr Ophtalmol 30 (1), 49

Pneumonia 

(2016): Broder MS+, Semin Arthritis Rheum 46(2), 246 [REVIEW]

Adverse effects 

(2021): Ma S+, Signal Transduct Target Ther 6(1), 83 [REVIEW] (passim)

(2021): Santiago T+, Rheumatology (Oxford) Jan, Online ahead of print [REVIEW]

(2020): Cheng W+, Front Pharmacol Sep, eCollection [REVIEW] (mild) (passim)

(2020): Sterne JAC+, JAMA Sep, Online ahead of print [REVIEW]

Adverse reactions attributed to entire drug class Corticosteroid, systemic

Bradycardia / sinus bradycardia 

(2019): Duffy C+, J Pediatr Hematol Oncol Apr, Epub ahead of print98%Pediatric (with induction chemotherapy)

Mania 

(2021): Chen P+, Cureus 13(1), e12594 (1 case / female)Geriatric

Sleep disturbances 

(2020): Cole JL, Fed Pract 37(6), 260-267 [REVIEW]

Diabetes mellitus 

(2015): Satyanarayanasetty D+, J Clin Diagn Res 9(5), Epub

Osteoporosis 

(2015): Satyanarayanasetty D+, J Clin Diagn Res 9(5), Epub

Cataract 

(2015): Satyanarayanasetty D+, J Clin Diagn Res 9(5), Epub

Adverse effects 

(2017): Aljebab F+, PLoS One 12(1), Epub [REVIEW]Pediatric

Adverse reactions attributed to entire drug class Covid-19 putative drug

Cardiovascular adverse effect 

(2020): Carpenter A+, Front Cardiovasc Med 7, 85 [REVIEW]

(2020): Giudicessi JR+, Mayo Clin Proc May, Online ahead of print [REVIEW]

(2020): Naksuk N+, Eur Heart J Acute Cardiovasc Care May, Epub ahead of print [REVIEW]

(2020): Sarayani A+, Res Social Adm Pharm Apr, Epub ahead of print [REVIEW]

(2020): Zhang D+, Zhongguo Zhong Yao Za Zhi (Chinese) 45(10), 2275-2286 [REVIEW]

Neuropsychiatric / neuropsychological adverse effect 

(2021): Borah P+, Front Mol Biosci 8, 627723

(2020): García CAC+, Gen Hosp Psychiatry Jun, Online ahead of print [REVIEW]

Gastrointestinal disorder / discomfort 

(2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print23%

Hepatic (liver) disorder / hepatic (liver) dysfunction 

(2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print14%

Thrombocytopenia 

(2020): Nham E+, Infect Chemother Apr, Epub ahead of print

Adverse effects 

(2021): Bérard A+, PLoS One 16(5), e0251746 [REVIEW] (in pregnancy)

(2021): Cheng Q+, Aging (Albany NY) Sep, Online ahead of print [REVIEW]

(2021): Cruciani F+, Recenti Prog Med 112(3), 195-206 [REVIEW]

(2021): Ommati MM+, J Biochem Mol Toxicol May, Online ahead of print [REVIEW]

(2021): Qiu R+, Medicine (Baltimore) 100(16), e25532 [REVIEW]

(2021): Wu SS+, Chin Med J (Engl) Jul, Online ahead of print [REVIEW]

(2020): Favilli A+, J Matern Fetal Neonatal Med Jun, Online ahead of print [REVIEW]

(2020): Griffiths G+, Trials 21(1), 544

(2020): Patil VM+, Life Sci May, Epub ahead of print [REVIEW]

(2020): Rhodes NJ+, medRxiv Jun, Preprint

(2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print38%

(2020): Svensson M, Lakartidningen (Swedish) Apr, 117

(2020): Wen CY+, Zhonghua Nei Ke Za Zhi (Chinese) May, Epub ahead of print

(2020): Zekarias A+, Drug Saf Sep, Online ahead of print [REVIEW]

(2020): Zhong H+, Pharmacol Res Apr, Epub ahead of print [REVIEW]

Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top